English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

New Kidney Disease Improving Global Outcomes guidelines represent a significant change from the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative, which indicate that the urinary albumin/ creatinine ratio is now integral to the classification of chronic kidney disease. The urinary albumin/creatinine ratio has been found to be fundamentally important for both the diagnosis and the prognosis of chronic kidney disease. It is now recommended that all patients with diabetes or hypertension be screened annually with this test. The presence of albuminuria helps decide the medications for the treatment of hypertension. This review discusses the importance of urine albumin–creatinine ratio in chronic kidney disease. Conclusion More research is needed to determine definitively whether or not the treatment of albuminuria delays the progression of chronic kidney disease and reduces mortality.

The importance urine albumin-creatinine ratio in the diagnosis and prognosis of chronic kidney disease